Gabriela Elisa Hirsch, Mariana Migliorini Parisi, Leo Anderson Meira Martins, Lílian Corrêa Costa-Beber, Cláudia Marlise Balbinotti Andrade, Florencia Mária Barbé Tuana, Silvia Resende Terra, Tassiane Dos Santos Ferrão, Roger Wagner, Tatiana Emanuelli, Fátima Theresinha Costa Rodrigues Guma
{"title":"Cytotoxic properties of <i>Thuya occidentalis</i> hydroalcoholic extract on androgen unresponsive prostate cancer cells.","authors":"Gabriela Elisa Hirsch, Mariana Migliorini Parisi, Leo Anderson Meira Martins, Lílian Corrêa Costa-Beber, Cláudia Marlise Balbinotti Andrade, Florencia Mária Barbé Tuana, Silvia Resende Terra, Tassiane Dos Santos Ferrão, Roger Wagner, Tatiana Emanuelli, Fátima Theresinha Costa Rodrigues Guma","doi":"10.1080/13813455.2024.2430488","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Androgen independent phase in prostate cancer (PCa) commonly limits the therapeutic efficacy. <i>Thuya occidentalis</i> through its main active compound, α-thujone, appears to be an option, considering its anti-proliferative, anti-metastatic and pro-apoptotic effects on hepatocellular carcinoma. However, studies on PCa are limited.</p><p><p><b>Objective:</b> To evaluate if <i>T. occidentalis</i> could be useful against androgen responsive and unresponsive PCa cells.</p><p><p><b>Methods:</b> Androgen responsive (LNCaP) and unresponsive (DU145 and PC3) cell lines were exposed to <i>T. occidentalis</i> hydroalcoholic extract (0.05 mL/mL) for different periods. Further, α-thujone was measured in the extract and tested in the cell lines.</p><p><p><b>Results:</b> <i>T. occidentalis</i> and α-thujone showed the highest cytotoxicity on LNCaP cells. In androgen unresponsive cells, <i>T. occidentalis</i> decreased cell viability and density, and promoted apoptosis, necrosis and cell cycle arrest, possibly associated with Cav-1 downregulation. The α-thujone present in the extract significantly LNCaP cells density, but did not affect DU145 and PC3 cells, suggesting that other compounds may also be cytotoxic to androgen unresponsive cells.</p>","PeriodicalId":8331,"journal":{"name":"Archives of Physiology and Biochemistry","volume":" ","pages":"1-11"},"PeriodicalIF":2.5000,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Physiology and Biochemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13813455.2024.2430488","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Androgen independent phase in prostate cancer (PCa) commonly limits the therapeutic efficacy. Thuya occidentalis through its main active compound, α-thujone, appears to be an option, considering its anti-proliferative, anti-metastatic and pro-apoptotic effects on hepatocellular carcinoma. However, studies on PCa are limited.
Objective: To evaluate if T. occidentalis could be useful against androgen responsive and unresponsive PCa cells.
Methods: Androgen responsive (LNCaP) and unresponsive (DU145 and PC3) cell lines were exposed to T. occidentalis hydroalcoholic extract (0.05 mL/mL) for different periods. Further, α-thujone was measured in the extract and tested in the cell lines.
Results:T. occidentalis and α-thujone showed the highest cytotoxicity on LNCaP cells. In androgen unresponsive cells, T. occidentalis decreased cell viability and density, and promoted apoptosis, necrosis and cell cycle arrest, possibly associated with Cav-1 downregulation. The α-thujone present in the extract significantly LNCaP cells density, but did not affect DU145 and PC3 cells, suggesting that other compounds may also be cytotoxic to androgen unresponsive cells.
期刊介绍:
Archives of Physiology and Biochemistry: The Journal of Metabolic Diseases is an international peer-reviewed journal which has been relaunched to meet the increasing demand for integrated publication on molecular, biochemical and cellular aspects of metabolic diseases, as well as clinical and therapeutic strategies for their treatment. It publishes full-length original articles, rapid papers, reviews and mini-reviews on selected topics. It is the overall goal of the journal to disseminate novel approaches to an improved understanding of major metabolic disorders.
The scope encompasses all topics related to the molecular and cellular pathophysiology of metabolic diseases like obesity, type 2 diabetes and the metabolic syndrome, and their associated complications.
Clinical studies are considered as an integral part of the Journal and should be related to one of the following topics:
-Dysregulation of hormone receptors and signal transduction
-Contribution of gene variants and gene regulatory processes
-Impairment of intermediary metabolism at the cellular level
-Secretion and metabolism of peptides and other factors that mediate cellular crosstalk
-Therapeutic strategies for managing metabolic diseases
Special issues dedicated to topics in the field will be published regularly.